Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress
MALVERN, Pa., March 31, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
MALVERN, Pa., March 31, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”)…
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”)…
~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of…
~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of…
WALTHAM, Mass., March 31, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
WALTHAM, Mass., March 31, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
$17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support…
$17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support…
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
REDWOOD CITY, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
REDWOOD CITY, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
David Southwell steps down; Gavin MacBeath, Ph.D., Chief Scientific and Operating Officer, to serve as…
David Southwell steps down; Gavin MacBeath, Ph.D., Chief Scientific and Operating Officer, to serve as…
OREM, Utah, March 31, 2023 (GLOBE NEWSWIRE) — Reflect Scientific Inc (OTCQB: RSCF), a provider…
OREM, Utah, March 31, 2023 (GLOBE NEWSWIRE) — Reflect Scientific Inc (OTCQB: RSCF), a provider…
• 2022 Product Revenue Increased to $54.1 Million, Up 13% over 2021 • Global End User…